New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
Kiwi manufacturer Keytone Dairy has expanded its range of dairy and nutritional products with two new formulations, which are expected to support further growth in Asia.
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
From infant formula and health food clampdowns in China to food contamination and supplements controversy in New Zealand, read the latest regulatory news in our monthly review.
Read about the latest omega-3 tech for expectant mothers and their offspring, what triggers FPIES, probiotics' gut and mental health benefits, and why breakfast may not affect weight management.
New Zealand’s natural products sector is facing yet another lengthy process of workshops, surveys and consultations to secure regulations that are fit-for-purpose, after the government signalled its intention to go back to the drawing board.
A recent Australian RCT has reported the positive effects of aged garlic extract on hypertension and other cardiovascular health markers and age-related conditions.
Australian medical R&D facility Medlab Clinical will see its nutraceutical product range sold at Priceline Pharmacy, one of the country's largest pharmacy groups, thanks to a deal with Australian Pharmaceutical Industries (API).
Read the latest news on aland's sports nutrition plans, Bod Australia's booming CBD and hemp business, Nissin's shift from cup noodles to nutricosmetics, and more in this month's brand round-up.
Swiss food giant Nestlé aims to step up its global fight against iron deficiency after acquiring a new food fortification technology developed by researchers in New Zealand.
Marinova has commenced a clinical trial to investigate the gut health benefits of its bioactive seaweed extract, Maritech fucoidan, on elite athletes, with the broader goal of entering the sports nutrition market.
GOED (the Global Organization for EPA and DHA) is disputing the results of an Australian study that claims that excessive oxidation is compromising the health benefits of fish oil supplements sold in Australasia.
Australian regulators and healthcare professionals have called out manufacturers of 'sunscreen pills', saying they are ineffective and possibly even harmful when ingested.
Australian firm Bod Australia reported a record US$872,240 (A$1.22m) revenue for Q4 2018, due largely to portfolio expansion and new distribution agreements.
